120 related articles for article (PubMed ID: 29285220)
21. The combination effects of bendamustine with antimetabolites against childhood acute lymphoblastic leukemia cells.
Goto S; Goto H; Yokosuka T
Int J Hematol; 2016 May; 103(5):572-83. PubMed ID: 26886449
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines.
Kano Y; Akutsu M; Tsunoda S; Izumi T; Kobayashi H; Mano H; Furukawa Y
Invest New Drugs; 2007 Feb; 25(1):31-40. PubMed ID: 16865529
[TBL] [Abstract][Full Text] [Related]
23. Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models.
Lehmann C; Friess T; Birzele F; Kiialainen A; Dangl M
J Hematol Oncol; 2016 Jun; 9(1):50. PubMed ID: 27353420
[TBL] [Abstract][Full Text] [Related]
24. Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation.
Choi YW; Jeong SH; Ahn MS; Lee HW; Kang SY; Choi JH; Park JS
J Korean Med Sci; 2015 Oct; 30(10):1416-22. PubMed ID: 26425037
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate.
Hill BT; Shellard SA; Hosking LK; Dempke WC; Fichtinger-Schepman AM; Tone T; Scanlon KJ; Whelan RD
Cancer Res; 1992 Jun; 52(11):3110-8. PubMed ID: 1591724
[TBL] [Abstract][Full Text] [Related]
26. THE EFFECT OF ANTIMETABOLITES ON THE RESPIRATION OF LEUKEMIC MOUSE CELLS.
WOODLIFF HJ
Blood; 1963 Aug; 22():199-208. PubMed ID: 14045303
[No Abstract] [Full Text] [Related]
27. The cytotoxic effects of gemtuzumab ozogamicin (mylotarg) in combination with conventional antileukemic agents by isobologram analysis in vitro.
Tanaka M; Kano Y; Akutsu M; Tsunoda S; Izumi T; Yazawa Y; Miyawaki S; Mano H; Furukawa Y
Anticancer Res; 2009 Nov; 29(11):4589-96. PubMed ID: 20032408
[TBL] [Abstract][Full Text] [Related]
28. Modulation of fluoropyrimidine cytotoxicity by methotrexate or 5-methyltetrahydrofolate in human leukemia cells in vitro.
Mini E; Mazzei T; Coronnello M; Criscuoli L; Gualtieri M; Periti P
Chemioterapia; 1984 Dec; 3(6):343-9. PubMed ID: 6241507
[TBL] [Abstract][Full Text] [Related]
29. The synergism of 6-mercaptopurine plus cytosine arabinoside followed by PEG-asparaginase in human leukemia cell lines (CCRF/CEM/0 and (CCRF/CEM/ara-C/7A) is due to increased cellular apoptosis.
Nandy P; Periclou AP; Avramis VI
Anticancer Res; 1998; 18(2A):727-37. PubMed ID: 9615712
[TBL] [Abstract][Full Text] [Related]
30. Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia.
Sharabani H; Izumchenko E; Wang Q; Kreinin R; Steiner M; Barvish Z; Kafka M; Sharoni Y; Levy J; Uskokovic M; Studzinski GP; Danilenko M
Int J Cancer; 2006 Jun; 118(12):3012-21. PubMed ID: 16395705
[TBL] [Abstract][Full Text] [Related]
31. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
[TBL] [Abstract][Full Text] [Related]
32. The clinical and hematological response of previously treated leukemic subjects to the antimetabolite 6-mercaptopurine.
WILSON SJ
Ann N Y Acad Sci; 1954 Dec; 60(2):499-507. PubMed ID: 14350562
[No Abstract] [Full Text] [Related]
33. [Antimetabolites in the treatment of acute human leukoses. Mechanism of action and conditioning factors in the cellular response to drugs. II].
Grignani F; Martelli M; Tonato M
Clin Ter; 1974 Apr; 69(2):153-76. PubMed ID: 4134598
[No Abstract] [Full Text] [Related]
34. Loss of retinoblastoma tumor suppressor protein makes human breast cancer cells more sensitive to antimetabolite exposure.
Derenzini M; Donati G; Mazzini G; Montanaro L; Vici M; Ceccarelli C; Santini D; Taffurelli M; Treré D
Clin Cancer Res; 2008 Apr; 14(7):2199-209. PubMed ID: 18381962
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
Dong YB; Yang HL; Elliott MJ; McMasters KM
Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
[TBL] [Abstract][Full Text] [Related]
36. [Antimetabolites].
Wilmanns W
Internist (Berl); 1971; 12():Suppl 1:127-35. PubMed ID: 4944750
[No Abstract] [Full Text] [Related]
37. Effect of methotrexate polyglutamates on thioguanine nucleotide concentrations during continuation therapy of acute lymphoblastic leukemia with mercaptopurine.
Dervieux T; Hancock M; Evans W; Pui CH; Relling MV
Leukemia; 2002 Feb; 16(2):209-12. PubMed ID: 11840287
[TBL] [Abstract][Full Text] [Related]
38. SIRT1 inhibition impairs non-homologous end joining DNA damage repair by increasing Ku70 acetylation in chronic myeloid leukemia cells.
Zhang W; Wu H; Yang M; Ye S; Li L; Zhang H; Hu J; Wang X; Xu J; Liang A
Oncotarget; 2016 Mar; 7(12):13538-50. PubMed ID: 26646449
[TBL] [Abstract][Full Text] [Related]
39. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
[TBL] [Abstract][Full Text] [Related]
40. [Effects of combination chemotherapy of MCNU with various anti-cancer agents].
Machida S; Ito Y; Hoshino A
Gan To Kagaku Ryoho; 1985 Feb; 12(2):298-302. PubMed ID: 3918506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
